Rgenta Therapeutics, a clinical-stage biotechnology company pioneering the development of a new class of oral small molecules ...
Posters detail large gene insertion and epigenetic editing capabilities, expanding ElevateBio’s gene editing toolbox– Additional presentations ...
Oral presentation highlights novel compact RT editor demonstrating first preclinical in vivo proof of concept for precise ...
Dyno Therapeutics to present new capsids and AI advancements in gene delivery at the 29th American Society of Gene & Cell Therapy Annual Meeting ...
Best of both modalities” approach combines the efficacy, safety and scalability of RNA therapeutics with the multi-year durability of gene therapiesPortfolio prioritizes rare, severe, lifelong ...
In an era when Washington seems incapable of finding common ground on virtually any issue, it's notable to encounter a policy area where stakeholders across the political spectrum agree. Gene ...
Earth's biodiversity is in crisis. An imminent "sixth mass extinction" threatens beloved and important wildlife. It also threatens to reduce the amount of genetic diversity—or variation—within species ...
A novel CRISPR-based technology can spread within bacterial populations to eliminate antibiotic resistance. In a potential breakthrough for tackling antibiotic resistance, researchers from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results